Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Nuclear Medicine

  Free Subscription


Articles published in Am J Cardiol

Retrieve available abstracts of 22 articles:
HTML format



Single Articles


    January 2024
  1. GREENWALD M, Gunberg S, Ball J, Garcia D, et al
    Hearing Loss As A Surrogate Marker For Early Atherosclerosis in A High-Risk Population: A Prospective Study.
    Am J Cardiol. 2024;211:191-192.
    PubMed    


  2. VILLINES TC, Rodriguez-Lozano P, Mallawaarachchi I, Williams MC, et al
    Disparities in Non-invasive Traditional and Advanced Testing for Coronary Artery Disease: Findings from the INCAPS-COVID 2 Study.
    Am J Cardiol. 2024 Jan 11:S0002-9149(24)00004.
    PubMed     Abstract available


    November 2023
  3. AL-SADAWI M, Tao M, Frye J, Dianati-Maleki N, et al
    The Use of Quality Improvement Interventions in Reducing Rarely Appropriate Cardiac Imaging.
    Am J Cardiol. 2023;207:349-355.
    PubMed     Abstract available


  4. GANNON MP, Cerci RJ, Valdiviezo C, Ostovaneh MR, et al
    Combined Computed Tomography Angiography-Computed Tomography Perfusion in the Identification and Prognostic Assessment of Myocardial Bridging from the CORE320 Study: 5-Year Follow-Up.
    Am J Cardiol. 2023;207:314-321.
    PubMed     Abstract available


    October 2023
  5. CHURCHILL R, Sykora D, Castrichini M, Arment C, et al
    Clinical Response to Tumor Necrosis Factor-alpha Inhibitor Therapy in the Management of Cardiac Sarcoidosis.
    Am J Cardiol. 2023;205:20-27.
    PubMed     Abstract available


    September 2023
  6. DE BORTOLI A, Culver DA, Kron J, Lehtonen J, et al
    An International Survey of Current Clinical Practice in the Treatment of Cardiac Sarcoidosis.
    Am J Cardiol. 2023;203:184-192.
    PubMed     Abstract available


    February 2023
  7. KANETA K, Takahama H, Tateishi E, Irie Y, et al
    Clinical Outcomes of Radiologic Relapse in Patients With Cardiac Sarcoidosis Under Immunosuppressive Therapies.
    Am J Cardiol. 2023;188:24-29.
    PubMed     Abstract available


    October 2022
  8. TRUJILLO L, Colombo R
    Hereditary Transthyretin Amyloidosis Cardiomyopathy: The South Florida Experience.
    Am J Cardiol. 2022;180:140-148.
    PubMed     Abstract available


  9. YAMAMOTO A, Nagao M, Fukushima K, Ando K, et al
    Adverse Cardiac Events in Cardiac Sarcoidosis Prediction by (123)I-betamethyl-p-iodophenyl-pentadecanoic Acid Single-Photon Emission Computed Tomography and Cardiac Magnetic Resonance Late Gadolinium Enhancement.
    Am J Cardiol. 2022;180:149-154.
    PubMed     Abstract available


    August 2022
  10. ALRESHQ R, Cozzolino M, Lilleness B, Pipilas A, et al
    Light Chain Testing Abnormalities Among Patients With Transthyretin Amyloid Cardiomyopathy Referred for Technetium-99m Pyrophosphate Imaging.
    Am J Cardiol. 2022 Aug 23. pii: S0002-9149(22)00755.
    PubMed     Abstract available


    July 2022
  11. GODWIN L, Zheng Z, Kundu S, Cousins R, et al
    Risk Factors Associated With New-Onset Myocardial Perfusion Abnormalities in Kidney Transplant Candidates.
    Am J Cardiol. 2022;174:84-88.
    PubMed     Abstract available


    April 2022
  12. HACHIYA S, Kosuge H, Fujita Y, Hida S, et al
    Performance of Hybrid Imaging in the Diagnosis of Coronary Artery Disease.
    Am J Cardiol. 2022 Apr 1. pii: S0002-9149(22)00236.
    PubMed     Abstract available


    March 2022
  13. BOURQUE JM, Schepart A, Bhambri R, Castano A, et al
    Temporal Trends in Diagnostic Testing Patterns for Wild-Type Transthyretin Amyloid Cardiomyopathy in the Medicare Fee-for-Service Population.
    Am J Cardiol. 2022;167:98-103.
    PubMed     Abstract available


    January 2022
  14. RAMSARAN E, Dai Q, Sundaresan D, Leblanc M, et al
    Mortality in Stable Coronary Disease in Patients With Intermediate- or High-Risk Myocardial Perfusion Imaging.
    Am J Cardiol. 2022 Jan 21. pii: S0002-9149(21)01239.
    PubMed     Abstract available


    December 2021
  15. NGUYEN FD, Rodriguez M, Krittanawong C, Witteles R, et al
    Misconceptions and Facts About Cardiac Amyloidosis.
    Am J Cardiol. 2021;160:99-105.
    PubMed     Abstract available


  16. MURUGIAH K, Chen L, Castro-Dominguez Y, Khera R, et al
    Scope of Practice of US Interventional Cardiologists from an Analysis of Medicare Billing Data.
    Am J Cardiol. 2021;160:40-45.
    PubMed     Abstract available


    November 2021
  17. OKONOGI T, Kawasaki T, Koga H, Orita Y, et al
    Comparison of Diagnostic Performance of Fractional Flow Reserve Derived from Coronary Computed Tomographic Angiography Versus Single-Photon Emission Computed Tomographic Myocardial Perfusion Imaging.
    Am J Cardiol. 2021;159:36-43.
    PubMed     Abstract available


    October 2021
  18. JACOBSON AF, Narula J, Tijssen J
    Analysis of Differences in Assessment of Left Ventricular Function on Echocardiography and Nuclear Perfusion Imaging.
    Am J Cardiol. 2021;156:85-92.
    PubMed     Abstract available


    June 2021
  19. KOLLURI N, Elwazir MY, Rosenbaum AN, Maklady FA, et al
    Effect of Corticosteroid Therapy in Patients With Cardiac Sarcoidosis on Frequency of Venous Thromboembolism.
    Am J Cardiol. 2021;149:112-118.
    PubMed     Abstract available


  20. JANUS SE, Al-Kindi SG, Hajjari J, Chami T, et al
    Anisocytosis Is Associated With Reduced Bone Marrow Activity Evaluated by Positron Emission Tomography.
    Am J Cardiol. 2021 Jun 11. pii: S0002-9149(21)00405.
    PubMed    


  21. CASE BC, Yang M, Qamer SZ, Kumar S, et al
    Pre-Operative Cardiovascular Testing before Liver Transplantation.
    Am J Cardiol. 2021 Jun 5. pii: S0002-9149(21)00366.
    PubMed     Abstract available


    December 2020
  22. MARTINEZ-SANCHEZ C, Azar-Manzur F, Gonzalez-Pacheco H, Amezcua-Guerra LM, et al
    Effectiveness and Safety of Extracorporeal Shockwave Myocardial Revascularization in Patients with Refractory Angina Pectoris and Heart Failure.
    Am J Cardiol. 2020 Dec 29. pii: S0002-9149(20)31416.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Nuclear Medicine is free of charge.